Vanda Pharmaceuticals (VNDA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 54,034 | 84,851 | 70,022 | 80,983 | 111,796 |
| Marketable Securities | 148,276 | 178,996 | 223,730 | 244,567 | 229,112 |
| Receivables | 56,879 | 54,578 | 50,541 | 44,993 | 44,603 |
| Inventories | 1,699 | 1,852 | 2,042 | 2,169 | 1,923 |
| TOTAL | $293,169 | $347,262 | $367,496 | $394,921 | $407,910 |
| Non-Current Assets | |||||
| PPE Net | 2,245 | 2,248 | 2,460 | 2,420 | 2,439 |
| Intangibles | 115,102 | 117,089 | 108,841 | 110,593 | 112,344 |
| Other Non-Current Assets | 23,009 | 22,349 | 122,343 | 116,812 | 109,243 |
| TOTAL | $140,356 | $141,686 | $233,644 | $229,825 | $224,026 |
| Total Assets | $433,525 | $488,948 | $601,140 | $624,746 | $631,936 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 60,620 | 68,297 | 47,619 | 57,119 | 45,279 |
| Other current liabilities | 74,962 | 76,865 | 70,251 | 64,370 | 58,644 |
| TOTAL | $135,582 | $145,162 | $117,870 | $121,489 | $103,923 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 13,393 | 12,524 | 14,463 | 13,845 | 13,649 |
| TOTAL | $17,178 | $16,600 | $17,271 | $16,928 | $16,596 |
| Total Liabilities | $152,760 | $161,762 | $135,141 | $138,417 | $120,519 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 60,136 | 59,108 | 59,097 | 59,089 | 58,934 |
| Common Shares | 60 | 59 | 59 | 59 | 59 |
| Retained earnings | -443,333 | -394,766 | -253,579 | -230,993 | -203,786 |
| Other shareholders' equity | 212 | 629 | 540 | 396 | 383 |
| TOTAL | $280,765 | $327,186 | $465,999 | $486,329 | $511,417 |
| Total Liabilities And Equity | $433,525 | $488,948 | $601,140 | $624,746 | $631,936 |